Electrocore Inc (ECOR) - News Archive

In a world where the hustle and bustle of modern life can often lead to increased stress and sleep-related issues, innovative solutions are continuously emerging to enhance well-being. One such solution has recently rec...

ROCKAWAY, N.J. In a significant development for the intersection of bioelectronic medicine and digital health, electroCore, Inc. (Nasdaq: ECOR), a company recognized for its innovative approaches to wellness, announced...

As the trend towards direct-to-consumer medical devices gains momentum, Electrocore Inc. has positioned itself at the forefront of this burgeoning market. The company s vagus nerve stimulator, Truvaga, is now available...

ElectroCore s Strategic Move: Strengthening Its Bioelectronic Wellness Portfolio Through the Quell PlatformIn a groundbreaking announcement made on November 8, 2024, ElectroCore has confirmed the strategic induction of...

As of November 8, 2024, ElectroCore, Inc. a leading player in the bioelectronic medicine and wellness sector, is positioning itself for future growth by announcing a significant addition to its leadership team. The publ...

Non-invasive Vagus Nerve Stimulation: A Potential Ally in Accelerating U.S. Air Force Pilot Training In the realm of military training, efficiency and mental acuity are paramount, particularly within the demanding envir...

Electrocore Inc., a pioneering bioelectronic medicine and wellness company, recently announced the appointment of Stephen Smith as the Vice President of Quality, Regulatory, and Compliance. Alongside this exciting addit...

: The integration of non-invasive vagus nerve stimulation (nVNS) into educational environments presents an innovative approach to enhancing cognitive functions, particularly in language acquisition. Recent clinical tria...

electroCore Joins Russell Microcap Index as Its Stock Receives Inclusion NodIn an exciting development for electroCore, Inc., the commercial-stage bioelectronic medicine and wellness company, it has been announced that...

In a move to boost its financial position, electroCore, Inc. recently announced the closing of a $9.3 million registered direct offering and concurrent private placements. The company, known for its bioelectronic medici...

IntroductionIn recent announcements, electroCore, Inc. (Nasdaq: ECOR) has revealed plans for a registered direct offering, along with concurrent private placements priced at market under Nasdaq Rules. These developments...

ElectroCore Strengthens Leadership Team with New SVP Appointment and Inducement GrantElectroCore, a leading bioelectronic medicine and wellness company, recently announced the appointment of Donald Melnikoff as the Seni...

ROCKAWAY, N.J. - Noted commercial-stage bioelectronic medicine and wellness company, electroCore, Inc., marked a significant milestone in its business evolution with the announcement of Truvaga Plus, an app-enabled prod...